Procoagulant Activity of Human Tumors
Author Information
Author(s): R. Sarodel, N. Marwaha, N.M. Gupta
Primary Institution: Postgraduate Institute of Medical Education & Research, Chandigarh, India
Hypothesis
Metastatic tumors have higher procoagulant activity compared to non-metastatic tumors and normal tissue.
Conclusion
The study found that metastatic tumors exhibited significantly higher procoagulant activity than non-metastatic tumors and normal tissue.
Supporting Evidence
- Metastatic breast tumors had a mean procoagulant activity of 76.1%, significantly higher than non-metastatic tumors at 11.3%.
- Metastatic gastrointestinal adenocarcinomas had a mean procoagulant activity of 120.5%, compared to 7.7% in non-metastatic cases.
- Metastatic ovarian carcinomas showed a mean procoagulant activity of 112.5%, significantly higher than normal ovarian tissue.
Takeaway
Cancer cells can make the blood clot more easily, which helps them spread to other parts of the body.
Methodology
Tumor samples were collected, processed, and analyzed for procoagulant activity using various assays.
Limitations
The study did not establish the exact origin of procoagulant activity in tumor homogenates.
Participant Demographics
Included various types of tumors: breast, gastrointestinal, thyroid, larynx, and mesenchymal tumors.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website